John P. Greer

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim, M. Bagot, Lauren Pinter‐Brown et al. · The Lancet Oncology · 2018 · 621 citations · Full text

Cutaneous T-cell Lymphoma, Lymphoid Neoplasia, Medicine +6

Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia.

Alan F. List, Catherine Spier, John P. Greer et al. · Journal of Clinical Oncology · 1993 · 280 citations

A Small-Cell-Predominant Variant of Primary Ki-1 (CD30)+ T-Cell Lymphoma

Marsha C. Kinney, Robert D. Collins, John P. Greer et al. · The American Journal of Surgical Pathology · 1993 · 252 citations

Acute Lymphoblastic Leukemia, Version 2.2015

Joseph Alvarnas, Patrick A. Brown, Patricia Aoun et al. · Journal of the National Comprehensive Cancer Network · 2015 · 239 citations · Full text

Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study.

Kevin E. Salhany, John B. Cousar, John P. Greer et al. · PubMed · 1988 · 236 citations · Full text